HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prognostic role of serum sialyl Lewisx (CD15s) in colorectal cancer.

AbstractOBJECTIVE:
Sialyl Lewis(x) (sLe(x)) is one ligand for E selectin (CD62E), a glycoprotein that is expressed on activated endothelial cells. Adhesion mediated by endothelial E selectin and sLe(x) expressed on human tumor cells could be relevant for the development of metastases. The aim of this study was to investigate whether or not a correlation exists between pre-operative levels of ganglioside serum sLe(x) and disease-free interval and survival in colorectal cancer patients.
PATIENTS AND METHODS:
Thirty Duke's B and 52 Duke's C patients undergoing resection for colorectal cancer were studied. The median follow-up time was 34.8 months. A pool of 57 sera from normal subjects was used as an Internal Normal Standard (INS). sLe(x) analyses were performed by a thin layer chromatography (TLC) immunostaining technique. Results were expressed as the ratio (R) between bands of INS and bands from each neoplastic serum.
RESULTS:
The median R value was 0.80 in normal subjects, 0.70 in Duke's B patients and 1.0 in Duke's C patients. No significant differences were detected between sLe(x) concentrations in sera from normal and neoplastic subjects (p = 0.1). Using an arbitrary cutoff of R = 0.9, the mean disease-free interval in the whole series was 47.4 months for R <0.9 and 126.0 months for R > or = 0.9 (p = 0.04). The survival time was 76.8 months for patients with R values <0.9 and 156.3 months for patients with R values > or =0.9 (p = 0.1).
CONCLUSIONS:
High serum levels of ganglioside sLe(x) significantly correlate with a favorable prognosis and with a lower occurrence of metastases. It is conceivable that soluble sLe(x) may compete with membrane-bound sLe(x) in the course of interactions between activated endothelium and tumor cells that have reached the circulation.
AuthorsMichela Paganuzzi, Barbara Bobbio, Paola Marroni, Rosa Filiberti, Giovanni Battista Secco, Carlo Enrico Grossi
JournalOncology (Oncology) Vol. 65 Issue 1 Pg. 52-9 ( 2003) ISSN: 0030-2414 [Print] Switzerland
PMID12837983 (Publication Type: Journal Article)
CopyrightCopyright 2003 S. Karger AG, Basel
Chemical References
  • Biomarkers, Tumor
  • Lewis X Antigen
  • Oligosaccharides
  • Sialyl Lewis X Antigen
Topics
  • Aged
  • Biomarkers, Tumor (blood)
  • Case-Control Studies
  • Chromatography, Thin Layer
  • Colorectal Neoplasms (blood, mortality, pathology, surgery)
  • Disease-Free Survival
  • Female
  • Humans
  • Italy
  • Lewis X Antigen (blood)
  • Male
  • Neoplasm Metastasis
  • Oligosaccharides (blood)
  • Prognosis
  • Sialyl Lewis X Antigen
  • Survival Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: